US3596641098
US3596641098
Fulgent Genetics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 598.18M EUR | 564.61M EUR | 458.73M EUR | 816.5M EUR |
Enterprise Value | 319.81M EUR | 547.72M EUR | 445.23M EUR | 773.98M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -15.75x | -- | -- | -- |
Price to Sales | 1.85x | 1.74x | 1.43x | 3.28x |
Price to Book | 0.6x | 0.56x | 0.44x | 0.73x |
EV/Revenue | 0.99x | 1.69x | 1.39x | 3.11x |
EV/EBITDA | -3.58x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -15.2% | -18.38% | -24.67% | -14.09% |